Financials data is unavailable for this security.
View more
Year on year Regenerative Medical Technology Group Inc had net income fall 78.21% from a loss of 5.51m to a larger loss of 9.81m despite a 57.49% increase in revenues from 1.53m to 2.41m.
| Gross margin | 70.91% |
|---|---|
| Net profit margin | -161.28% |
| Operating margin | 33.44% |
| Return on assets | -158.36% |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Regenerative Medical Technology Group Inc fell by 1.11m. Cash Flow from Financing was negative, which signals that this company did not need to attract significant financing from outside sources. In addition the company used 419.20k for operations while cash used for investing totalled 385.60k.
| Cash flow per share | -0.387 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -2.13 |
|---|---|
| Tangible book value per share | -2.28 |
More ▼
Balance sheet in USDView more
| Current ratio | 0.0334 |
|---|---|
| Quick ratio | 0.0331 |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
